Retropharyngeal Abscess Treatment Market, Global Outlook and Forecast 2022-2028

February 2022 | 68 pages | ID: R42CC2A542AAEN
Market Monitor Global

Abstracts

A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection.

This report contains market size and forecasts of Retropharyngeal Abscess Treatment in Global, including the following market information:

Global Retropharyngeal Abscess Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Retropharyngeal Abscess Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Retropharyngeal Abscess Treatment include Pfizer, Sanofi, Novartis, Johnson & Johnson, GlaxoSmithKline, Merck, AstraZeneca, Mylan and Teva pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retropharyngeal Abscess Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Retropharyngeal Abscess Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Retropharyngeal Abscess Treatment Market Segment Percentages, by Type, 2021 (%)

• Antibiotics
• Pain Killers
• Surgical Drainage
• Others

Global Retropharyngeal Abscess Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Retropharyngeal Abscess Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Retropharyngeal Abscess Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Retropharyngeal Abscess Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Retropharyngeal Abscess Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Retropharyngeal Abscess Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Sanofi
• Novartis
• Johnson & Johnson
• GlaxoSmithKline
• Merck
• AstraZeneca
• Mylan
• Teva pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Retropharyngeal Abscess Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Retropharyngeal Abscess Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RETROPHARYNGEAL ABSCESS TREATMENT OVERALL MARKET SIZE

2.1 Global Retropharyngeal Abscess Treatment Market Size: 2021 VS 2028
2.2 Global Retropharyngeal Abscess Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Retropharyngeal Abscess Treatment Players in Global Market
3.2 Top Global Retropharyngeal Abscess Treatment Companies Ranked by Revenue
3.3 Global Retropharyngeal Abscess Treatment Revenue by Companies
3.4 Top 3 and Top 5 Retropharyngeal Abscess Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Retropharyngeal Abscess Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retropharyngeal Abscess Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Retropharyngeal Abscess Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Retropharyngeal Abscess Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Retropharyngeal Abscess Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics
  4.1.3 Pain Killers
  4.1.4 Surgical Drainage
  4.1.5 Others
4.2 By Type - Global Retropharyngeal Abscess Treatment Revenue & Forecasts
  4.2.1 By Type - Global Retropharyngeal Abscess Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Retropharyngeal Abscess Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Retropharyngeal Abscess Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Retropharyngeal Abscess Treatment Revenue & Forecasts
  5.2.1 By Application - Global Retropharyngeal Abscess Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Retropharyngeal Abscess Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Retropharyngeal Abscess Treatment Market Size, 2021 & 2028
6.2 By Region - Global Retropharyngeal Abscess Treatment Revenue & Forecasts
  6.2.1 By Region - Global Retropharyngeal Abscess Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Retropharyngeal Abscess Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Retropharyngeal Abscess Treatment Revenue, 2017-2028
  6.3.2 US Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.3.3 Canada Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.3.4 Mexico Retropharyngeal Abscess Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Retropharyngeal Abscess Treatment Revenue, 2017-2028
  6.4.2 Germany Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.4.3 France Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.4.4 U.K. Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.4.5 Italy Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.4.6 Russia Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.4.8 Benelux Retropharyngeal Abscess Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Retropharyngeal Abscess Treatment Revenue, 2017-2028
  6.5.2 China Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.5.3 Japan Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.5.4 South Korea Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.5.6 India Retropharyngeal Abscess Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Retropharyngeal Abscess Treatment Revenue, 2017-2028
  6.6.2 Brazil Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.6.3 Argentina Retropharyngeal Abscess Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Retropharyngeal Abscess Treatment Revenue, 2017-2028
  6.7.2 Turkey Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.7.3 Israel Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Retropharyngeal Abscess Treatment Market Size, 2017-2028
  6.7.5 UAE Retropharyngeal Abscess Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Retropharyngeal Abscess Treatment Major Product Offerings
  7.1.4 Pfizer Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Retropharyngeal Abscess Treatment Major Product Offerings
  7.2.4 Sanofi Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.2.5 Sanofi Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Retropharyngeal Abscess Treatment Major Product Offerings
  7.3.4 Novartis Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Retropharyngeal Abscess Treatment Major Product Offerings
  7.4.4 Johnson & Johnson Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Retropharyngeal Abscess Treatment Major Product Offerings
  7.5.4 GlaxoSmithKline Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Retropharyngeal Abscess Treatment Major Product Offerings
  7.6.4 Merck Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Retropharyngeal Abscess Treatment Major Product Offerings
  7.7.4 AstraZeneca Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Mylan
  7.8.1 Mylan Corporate Summary
  7.8.2 Mylan Business Overview
  7.8.3 Mylan Retropharyngeal Abscess Treatment Major Product Offerings
  7.8.4 Mylan Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.8.5 Mylan Key News
7.9 Teva pharmaceutical
  7.9.1 Teva pharmaceutical Corporate Summary
  7.9.2 Teva pharmaceutical Business Overview
  7.9.3 Teva pharmaceutical Retropharyngeal Abscess Treatment Major Product Offerings
  7.9.4 Teva pharmaceutical Retropharyngeal Abscess Treatment Revenue in Global Market (2017-2022)
  7.9.5 Teva pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Retropharyngeal Abscess Treatment Market Opportunities & Trends in Global Market
Table 2. Retropharyngeal Abscess Treatment Market Drivers in Global Market
Table 3. Retropharyngeal Abscess Treatment Market Restraints in Global Market
Table 4. Key Players of Retropharyngeal Abscess Treatment in Global Market
Table 5. Top Retropharyngeal Abscess Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Retropharyngeal Abscess Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Retropharyngeal Abscess Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Retropharyngeal Abscess Treatment Product Type
Table 9. List of Global Tier 1 Retropharyngeal Abscess Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retropharyngeal Abscess Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Retropharyngeal Abscess Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Retropharyngeal Abscess Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Retropharyngeal Abscess Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Retropharyngeal Abscess Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Retropharyngeal Abscess Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Retropharyngeal Abscess Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Retropharyngeal Abscess Treatment Product Offerings
Table 32. Pfizer Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Retropharyngeal Abscess Treatment Product Offerings
Table 35. Sanofi Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Retropharyngeal Abscess Treatment Product Offerings
Table 38. Novartis Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Retropharyngeal Abscess Treatment Product Offerings
Table 41. Johnson & Johnson Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Retropharyngeal Abscess Treatment Product Offerings
Table 44. GlaxoSmithKline Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Retropharyngeal Abscess Treatment Product Offerings
Table 47. Merck Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Retropharyngeal Abscess Treatment Product Offerings
Table 50. AstraZeneca Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Mylan Corporate Summary
Table 52. Mylan Retropharyngeal Abscess Treatment Product Offerings
Table 53. Mylan Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Teva pharmaceutical Corporate Summary
Table 55. Teva pharmaceutical Retropharyngeal Abscess Treatment Product Offerings
Table 56. Teva pharmaceutical Retropharyngeal Abscess Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Retropharyngeal Abscess Treatment Segment by Type in 2021
Figure 2. Retropharyngeal Abscess Treatment Segment by Application in 2021
Figure 3. Global Retropharyngeal Abscess Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Retropharyngeal Abscess Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Retropharyngeal Abscess Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Retropharyngeal Abscess Treatment Revenue in 2021
Figure 8. By Type - Global Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 12. US Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 24. China Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Retropharyngeal Abscess Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Retropharyngeal Abscess Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mylan Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva pharmaceutical Retropharyngeal Abscess Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)